GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Muller & Phipps (India) Ltd (BOM:501477) » Definitions » Debt-to-Equity

Muller & Phipps (India) (BOM:501477) Debt-to-Equity : -0.49 (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Muller & Phipps (India) Debt-to-Equity?

Muller & Phipps (India)'s Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹0.00 Mil. Muller & Phipps (India)'s Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹7.35 Mil. Muller & Phipps (India)'s Total Stockholders Equity for the quarter that ended in Sep. 2024 was ₹-14.90 Mil. Muller & Phipps (India)'s debt to equity for the quarter that ended in Sep. 2024 was -0.49.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Muller & Phipps (India)'s Debt-to-Equity or its related term are showing as below:

BOM:501477' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.6   Med: -0.49   Max: -0.37
Current: -0.49

During the past 13 years, the highest Debt-to-Equity Ratio of Muller & Phipps (India) was -0.37. The lowest was -0.60. And the median was -0.49.

BOM:501477's Debt-to-Equity is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 0.47 vs BOM:501477: -0.49

Muller & Phipps (India) Debt-to-Equity Historical Data

The historical data trend for Muller & Phipps (India)'s Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Muller & Phipps (India) Debt-to-Equity Chart

Muller & Phipps (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.43 -0.60 -0.59 -0.52 -0.59

Muller & Phipps (India) Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.58 N/A -0.59 N/A -0.49

Competitive Comparison of Muller & Phipps (India)'s Debt-to-Equity

For the Pharmaceutical Retailers subindustry, Muller & Phipps (India)'s Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Muller & Phipps (India)'s Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Muller & Phipps (India)'s Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Muller & Phipps (India)'s Debt-to-Equity falls into.



Muller & Phipps (India) Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Muller & Phipps (India)'s Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Muller & Phipps (India)'s Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Muller & Phipps (India)  (BOM:501477) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Muller & Phipps (India) Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Muller & Phipps (India)'s Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Muller & Phipps (India) Business Description

Traded in Other Exchanges
N/A
Address
204, Madhva Commercial Premises, C-4, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400051
Muller & Phipps (India) Ltd is engaged in the marketing of over-the-counter medical preparation and home care products. The operating segments of the company are Cosmetic/toiletry, Medicated preparation, and Others, of which a majority of the revenue is derived from the Medical preparation segment. The company's product portfolio includes medicated dental products, ayurvedic skin ointment and home care products. Its medicated dental products include cavisan and cavifast, Ayurvedic skin ointment product is Nixoderm, and Home care product is Alfa Plus.

Muller & Phipps (India) Headlines

No Headlines